Encompassing all Executive through Board Positions in Life Sciences

Director of the Board

Yes

Chief Executive Officer

Yes

Chief Business Officer

Leading publicly traded biopharmaceutical stem cell company.

No

Chairman of the Board

Yes

Chief Financial Officer

Formerly Aastrom Biosciences

Yes

Chief Operating Officer

Yes

Chief Scientific Officer

Leading publicly traded monoclonal antibody & oncology company

No

Executive Vice President, Orthopedics and Chief Operating Officer

Formerly BioMimetic Therapeutics, Inc.

Yes

In The News

LONDON–(BUSINESS WIRE)–#InfectiousDiseases–Technavio has published a new report on the drug development pipeline for uveal melanoma, including a detailed study of the pipeline molecules.

LONDON–(BUSINESS WIRE)–#RareDiseases–Technavio has published a new report on the drug development pipeline for urinary incontinence, including a detailed study of the pipeline molecules.

LONDON–(BUSINESS WIRE)–#RareDiseases–Technavio has published a new report on the drug development pipeline for mucositis, including a detailed study of the pipeline molecules

LONDON–(BUSINESS WIRE)–#Healthcare–Technavio has published a new report on the drug development pipeline for hypogonadism, including a detailed study of the pipeline molecules.

LONDON–(BUSINESS WIRE)–#Healthcare–The global liquid biopsy market 2018-2022 is expected to post a CAGR of more than 34% during the forecast period, according to Technavio.

LONDON–(BUSINESS WIRE)–#LabEquipment–The blood bank refrigerators market in the US 2018-2022 is expected to post a CAGR of around 6% during the forecast period, according to Technavio.

Upcoming Events

ROTH Capital Partners 31st Annual Conference
Orange County, CA March 17-19
Oppenheimer & Co. 29th Annual Healthcare Conference
New York, NY March 19-20
J.P. Morgan 8th Annual Napa Valley Healthcare Forum
San Francisco, CA March 26-28

See More Events